Squarepoint’s Pulmonx LUNG Stock Holding History

Squarepoint’s Portfolio LUNG Stock Details LUNG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$559K	Buy	292,462 +108,904	+59%	+$205K	﹤0.01%	3288
2026 Q2	$239K	Buy	183,558 +101,066	+123%	+$139K	﹤0.01%	3957
2026 Q1	$106K	Buy	82,492 +41,241	+100%	+$68.1K	﹤0.01%	4057
2025 Q4	$91.2K	Buy	+41,251	New	+$77.6K	﹤0.01%	4050
2025 Q3	–	Sell	-12,742	Closed	-$33K	–	4720
2025 Q2	$33K	Buy	12,742 +1,062	+9%	+$4.19K	﹤0.01%	4355
2025 Q1	$78.6K	Sell	11,680 -79,775	-87%	-$565K	﹤0.01%	4273
2024 Q4	$621K	Sell	91,455 -29,682	-25%	-$195K	﹤0.01%	3535
2024 Q3	$1M	Sell	121,137 -23,272	-16%	-$168K	﹤0.01%	2602
2024 Q2	$916K	Buy	144,409 +104,432	+261%	+$803K	﹤0.01%	2617
2024 Q1	$371K	Buy	+39,977	New	+$469K	﹤0.01%	3250
2023 Q1	–	Sell	-82,059	Closed	-$692K	–	3537
2022 Q4	$692K	Buy	82,059 +43,118	+111%	+$410K	﹤0.01%	2080
2022 Q3	$649K	Sell	38,941 -80,745	-67%	-$1.49M	﹤0.01%	2066
2022 Q2	$1.76M	Buy	+119,686	New	+$2.47M	0.01%	1277
2022 Q1	–	Sell	-12,561	Closed	-$403K	–	3236
2021 Q4	$403K	Sell	12,561 -8,359	-40%	-$305K	﹤0.01%	2289
2021 Q3	$753K	Buy	20,920 +14,778	+241%	+$581K	﹤0.01%	1731
2021 Q2	$271K	Buy	+6,142	New	+$267K	﹤0.01%	2604

Other funds holding LUNG

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

CFM Wealth Partners Austin, Texas $803M AUM 41.47% 1-Year Est. Return

Redhawk Wealth Advisors Minneapolis, Minnesota $987M AUM 25.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Brighton Jones LLC Seattle, Washington $5.73B AUM 24.99% 1-Year Est. Return

Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return

Squarepoint's LUNG Position: Q3 2026 in Review

Squarepoint increased its Pulmonx (LUNG) stake by 59% in Q3 2026, buying an estimated $205K and bringing the position to 292,462 shares worth $559K. The position accounts for ﹤0.01% of the portfolio, ranked #3288.

Squarepoint first reported a position in LUNG in Q2 2021 and has held it in 16 quarters since. The position peaked at $1.76M in Q2 2022. 33 funds tracked by Wall St. Rank hold LUNG as of Q3 2026.

Squarepoint held 292,462 shares of Pulmonx worth $559K as of Q3 2026.
Squarepoint bought 108,904 Pulmonx shares in Q3 2026, an estimated $205K.
Pulmonx made up ﹤0.01% of Squarepoint's portfolio in Q3 2026, its #3288 holding.
Squarepoint first reported a position in Pulmonx in Q2 2021 and has held it in 16 quarters since.
Squarepoint's Pulmonx position peaked at $1.76M in Q2 2022.
33 funds tracked by Wall St. Rank held Pulmonx as of Q3 2026.

Based on Squarepoint's 13F filing for Q3 2026, filed 9 Nov 2026.